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The small GTPase ADP-ribosylation factor 6 (ARF6) plays crucial roles in a wide variety of cell func-
tions. To better understand the molecular mechanisms of ARF6-mediated signaling and cellular
functions, we sought new ARF6-binding proteins in the mouse brain. We identiﬁed the signaling
scaffold protein JNK-interacting protein 3 (JIP3), which is exclusively expressed in neurons, as a
downstream effector of ARF6. Overexpression of a unique dominant negative mutant of ARF6,
which was unable to interact with JIP3, and knockdown of JIP3 in mouse cortical neurons stimu-
lated the elongation and branching of neurites. These results provide evidence that ARF6/JIP3 signal-
ing regulates neurite morphogenesis.
Structured summary:
MINT-7892698: PIP5K gamma 661 (uniprotkb:O70161) physically interacts (MI:0915) with Arf6 (uni-
protkb:P62331) by anti tag coimmunoprecipitation (MI:0007)
MINT-7892333, MINT-7892573, MINT-7892594, MINT-7892629, MINT-7892644, MINT-7892522, MINT-
7892716: Arf6 (uniprotkb:P62331) physically interacts (MI:0915) with JLP (uniprotkb:Q58A65) by anti tag
coimmunoprecipitation (MI:0007)
MINT-7892509: Arf6 (uniprotkb:P62331) physically interacts (MI:0915) with JIP3 (uniprotkb:Q9ESN9) by
pull down (MI:0096)
MINT-7892770: Arf6 (uniprotkb:P62331) binds (MI:0407) to JIP3 (uniprotkb:Q9ESN9) by pull down
(MI:0096)
MINT-7892755: Arf6 (uniprotkb:P62331) binds (MI:0407) to JLP (uniprotkb:Q58A65) by pull down
(MI:0096)
MINT-7892289, MINT-7892314: Arf6 (uniprotkb:P62331) physically interacts (MI:0915) with JLP (uni-
protkb:Q58A65) by pull down (MI:0096)
MINT-7892353, MINT-7892615, MINT-7892657, MINT-7892672, MINT-7892549, MINT-7892738: Arf6
(uniprotkb:P62331) physically interacts (MI:0915) with JIP3 (uniprotkb:Q9ESN9) by anti tag coimmuno-
precipitation (MI:0007)
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SA.1. Introduction
The mammalian small GTPase ADP-ribosylation factor (ARF)
family consists of six related gene products, ARF1–6, which are
subdivided into three classes based on their sequence homology.
Class I and II ARFs, ARF1–3 and ARF4–5, respectively, localize pri-
marily to perinuclear organelles and are implicated in intracellular
vesicle trafﬁcking. The class III ARF, ARF6, localizes mainly at the
plasma membrane and plays roles in a wide variety of cellular
events, such as endocytosis, exocytosis, membrane rufﬂelsevier B.V. All rights reserved.
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molecular mechanisms by which ARF6 regulates these cell events
remain largely unknown.
One possible approach to better understand the molecular
mechanisms of ARF6-mediated signaling is to identify the down-
stream effectors of ARF6. By this approach, we have successfully
demonstrated that the lipid kinase phosphatidylinositol 4-phos-
phate 5-kinase (PIP5K) functions as a downstream effector of
ARF6 to couple the signal of epidermal growth factor to membrane
rufﬂe formation [3]. Although several target molecules of ARF6
have been identiﬁed [1,2], to clearly understand the multiple func-
tions of ARF6, new downstream effectors of ARF6 still need to be
identiﬁed.
In this study, we identiﬁed JIP3, a signaling scaffold protein
exclusively expressed in neurons, as a novel partner protein of
ARF6. Finally, we demonstrated that interaction of ARF6 with
JIP3 regulates neurite morphogenesis of mouse cortical neurons.
2. Materials and methods
2.1. Antibodies, plasmids, recombinant proteins, and analysis of
intracellular protein–protein interactions
Antibodies, plasmids, recombinant proteins, and analysis of
protein–protein interactions in the cell are described in Supple-
mentary Materials and Methods.
2.2. Detection of ARF6-binding proteins in mouse brain cytosol
The active (ARF6Q67L) and inactive (ARF6T27N) mutants of
ARF6 tagged with glutathione S-transferase at the N-terminus
and with FLAG at the C-terminus were expressed in Escherichia
coli. After lysis of E. coli, these ARF6 mutants were trapped onFig. 1. Identiﬁcation of JIP3 and JLP as novel target molecules of ARF6. (A) Detection o
ARF6T27N-resins were detected by SDS–PAGE and subsequent SYPRO Ruby staining. (
binding domain; SH3, Src-homology domain 3; PTB, phosphotyrosine-binding domain; CC
proteins bound to ARF6Q67L. Protein samples obtained in A were immunoblotted with an
form of ARF6. JIP family members and ARF6Q67L or ARF6T27N were coexpressed in HEK2
of ARF isoforms for the interaction with JIP3 and JLP. Binding of JIP3 and JLP to the actiglutathione-Sepharose resin (GE Healthcare) and incubated with
PreScission protease (GE Healthcare) at 4 C for 12 h to release
the ARF6-FLAG mutants from the resins. The released ARF6-FLAG
mutants were immobilized on anti-FLAG M2 resin (Sigma). The
ARF6Q67L- and ARF6T27N-resins thus prepared were incubated
with guanosine 50-O-(thio)triphosphate and GDP, respectively, at
30 C for 20 min and then with mouse brain cytosol (7.6 mg
protein) at 4 C for 12 h in buffer (20 mM Tris–HCl pH 7.5,
1 mM EGTA, 2 mM MgCl2, 1% Triton X-100, and 1 mM PMSF).
After the resins were thoroughly washed, proteins bound to
these ARF6 mutant-resins were separated on 12% gels by SDS–
PAGE and visualized by SYPRO Ruby staining (Bio-Rad) or
immunoblotting.
2.3. Identiﬁcation of ARF6Q67L-binding proteins by MALDI-QIT/TOF
MS
Proteins bound to the ARF6Q67L-resin were subjected to in-gel
tryptic digestion followed by MS and MS/MS analyses with an AX-
IMA-QIT/TOF instrument (Shimadzu Biotech, Kyoto, Japan) as de-
scribed previously [4]. To identify the proteins, MS and MS/MS
spectra were searched against NCBInr databases using the MASCOT
search engine (peptide mass ﬁngerprint and MS/MS ion search,
Matrix Science).
2.4. Primary culture of mouse cortical neurons, transfection, and
confocal immunoﬂuorescence microscopy
Primary culture of cortical neurons and transfection are de-
scribed in Supplementary Materials and Methods. The immunoﬂu-
orescence analyses were performed according to the method
described by Nakano-Kobayashi et al. [5] with minor modiﬁca-
tions. For details, see Supplementary Materials and Methods.f ARF6-binding proteins in mouse brain cytosol. Proteins bound to ARF6Q67L- and
B) Schematic representation of domain structures of JIP family members. JB, JNK-
, coiled-coil domain; LZ, leucine zipper domain. (C) Detection of JIP3 and JLP in p170
ti-JIP3 and anti-JLP antibodies. (D) Speciﬁc interaction of JIP3 and JLP with the active
93T cells, and their interaction was detected by immunoprecipitation. (E) Speciﬁcity
ve mutants of ARF1, ARF5, and ARF6 were detected as described in (D).
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3.1. Identiﬁcation of JIP3 and JLP as novel target proteins of ARF6
We sought ARF6-interacting proteins in mouse brain cytosol
using resin-immobilized ARF6Q67L and ARF6T27N (Fig. 1A). A pro-
tein with an apparent molecular weight of 170 kDa (p170) that
bound to ARF6Q67L but not to ARF6T27N was identiﬁed as the c-
Jun N-terminal kinase (JNK)-interacting leucine zipper protein
(JLP), a member of the JNK-interacting protein (JIP) family [6], by
MALDI-QIT/TOF mass spectrometry, indicating that JLP is a novel
target protein of the active form of ARF6.
The JIP family comprises JIP1, JIP2, JIP3, and JLP. JIP3 and JLP are
highly homologous in their sequences and domain structures
(Fig. 1B), indicating that ARF6Q67L binds JIP3 as well as JLP. As ex-Fig. 2. Identiﬁcation of amino acid residues in ARF6 critical for the interaction with JIP
Asterisk denotes the position of Q67L mutation on ARF6 or Q71L mutation on ARF5. (B)
Fig. 1D. (C) Determination of amino acid residues in ARF6 critical for the interaction wi
described in Fig. 1D. (D) Complete loss of interaction for ARF6Q67L with JIP3/JLP by triple
was analyzed as described in Fig. 1D. (E) Ability of ARF6Q67LTriM to interact with PIP5K
as described in Fig. 1D.pected, the p170 proteins bound to the ARF6Q67L-resin were rec-
ognized by both anti-JIP3 and anti-JLP antibodies (Fig. 1C). Speciﬁc
interaction of the active form of ARF6 with JLP and JIP3 was also
observed in the cell. Immunoprecipitation of ARF6Q67L-FLAG
coexpressed with green ﬂuorescent protein (GFP)-tagged JIP family
members in HEK293T cells coprecipitated JLP and JIP3 (Fig. 1D).
We also found that the leucine zipper (LZ) region in JIP3 and the
LZII region in JLP are the binding sites for ARF6 (for details, see Sup-
plementary Results).
To examine the speciﬁcity of ARF isoforms in the interaction
with JIP3 and JLP, the active mutants of ARF1, ARF5, and ARF6,
which are the representatives of class I, II, and III ARFs, respec-
tively, were coexpressed with JIP3 or JLP in HEK293T cells, and
the interaction was examined. As shown in Fig. 1E, the active mu-
tant of ARF6 speciﬁcally interacted with JIP3 and JLP.3/JLP. (A) Schematic representation of ARF6Q67L mutants employed in this study.
Interaction of ARF6 mutants with JIP3 and JLP, which were analyzed as described in
th JIP3/JLP. Interaction of point-mutated ARF6Q67Ls with JIP3/JLP was analyzed as
mutations in ARF6Q67L. Interaction of ARF6Q67LTriM and ARF6Q67L with JIP3/JLP
c661. Interaction of ARF6Q67LTriM and ARF6Q67L with PIP5Kc661 was determined
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with JIP3 and JLP
As an ARF6 mutant able to speciﬁcally interfere with the inter-
action with JIP3 and JLP would be a very useful tool to investigate
ARF6/JIP3- and ARF6/JLP-mediated cellular functions, we investi-
gated which amino acid residues in ARF6 are critical for the bind-
ing to JIP3 and JLP. Since ARF5 failed to interact with JIP3/JLP, we
constructed cDNAs encoding an active mutant of ARF6/5 chimera,
ARF(N6–C5)Q67L, composed of 1–76 amino acid residues of ARF6
and 81–180 amino acid residues of ARF5, and a deletion mutant,
ARF6(D1–11)Q67L (Fig. 2A), and the interaction was examined
by immunoprecipitation from HEK293T cells. Both ARF(N6–
C5)Q67L and ARF6(D1–11)Q67L interacted with JIP3 and JLP
(Fig. 2B), indicating that the region corresponding to the 12–76
amino acid residues of ARF6 is important for the interaction. SinceFig. 3. ARF6/JIP3 regulates neurite morphogenesis of cortical neurons. Mouse cortical neu
or JIP3 siRNA with or without siRNA-resistant JIP3 (E), and stained with the anti-GFP antib
Knockdown of endogenous JIP3 and the recovery of the JIP3 expression by the JIP3 siRN
(Supplementary Figs. 2 and 3). Neurite branch points per neurite (B and F), total neurite l
transfected neurons were analyzed. Scale bars, 20 lm. Data are the means ± S.E.M. of ateight amino acid residues in this region of ARF6 are divergent from
those of ARF5, those in ARF6Q67L were point-mutated, and the
interaction was examined (Fig. 2C). Point mutations of L19V,
T53E, and K58C weakened the interaction with JIP3 and JLP. In
addition, the point mutation of N60T of ARF6Q67L reduced the
interaction with JLP. These results suggest that these four amino
acid residues in ARF6 are substantially critical for the interaction
with JIP3/JLP. It has been reported that three amino acid residues
in ARF6, T53, K58, and N60, locate close to the interswitch effector
domain surface, and one amino acid residue, L19, is buried inside
the ARF6 molecule [7]. This report led us to examine the
interaction of the T53E/K58C/N60T triple mutant of ARF6Q67L
(ARF6Q67LTriM). ARF6Q67LTriM completely lost its ability to
interact with JIP3/JLP (Fig. 2D). Importantly, interaction of
ARF6Q67LTriM with other ARF6 effectors, PIP5K (Fig. 2E) and
GGA3 (data not shown), was not impaired. These results indicaterons were cotransfected with GFP and HA-tagged wild type or mutants of ARF6 (A),
ody to observe the morphology under a confocal ﬂuorescence microscope (A and E).
A-resistant plasmid were conﬁrmed in cultured cortical neurons and HEK293T cells
ength (C and G), and number of neurites extended from the cell bodies (D and H) of
least three independent experiments. *P < 0.05; **P < 0.01.
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especially crucial for the interaction with JIP3 and JLP, consistent
with the report describing the crystal structure of the ARF6/JLP
complex [8]. Thus, ARF6TriM could be a useful dominant negative
mutant for investigating the physiological signiﬁcance of ARF6/JIP3
and ARF6/JLP signaling.
3.3. ARF6/JIP3 signaling regulates neurite morphogenesis of cortical
neurons
As JIP3 is speciﬁcally expressed in neurons [9], we speculated
that ARF6/JIP3 signaling couples to neurite morphogenesis. To ad-
dress this issue, the effects of ARF6 mutants on the morphology ofFig. 4. Regulation of axonal and dendritic morphology by ARF6/JIP3. Mouse cortical
neurons were cotransfected with GFP and HA-tagged wild type or mutants of ARF6
and immunostained with anti-GFP antibody. The morphology of the neurons was
then observed under a ﬂuorescence microscope (A). Total axon (B) and dendrite
length (C), number of axon tips (D), and dendrite tips per dendrite (E) of the
transfected neurons were analyzed. Axons and dendrites were identiﬁed by their
morphological characteristics (A). For quantiﬁcations of the data (B–E), neurons
were immunostained with anti-Tau1 and anti-MAP2 antibodies. Scale bars, 80 lm.
Data are the means ± S.E.M. of at least three independent experiments. *P < 0.05.mouse cortical neurons were examined. When ARF6T27N and
ARF6TriM were overexpressed in neurons, elongation and branch-
ing of neurites were stimulated, whereas they were inhibited by
overexpression of wild type ARF6 (Fig. 3A–C), consistent with re-
ports on hippocampal neurons [10,11]. The number of neurites
per neuron was slightly, if at all, increased by overexpression of
ARF6T27N but was not affected by ARF6TriM (Fig. 3D). Similarly,
knockdown of JIP3 enhanced both neurite elongation and branch-
ing, although the number of neurites was not affected (Fig. 3E–H).
These JIP3 knockdown effects were blocked by the cotransfection
of the siRNA-resistant plasmid for JIP3 (Fig. 3E–H). Knockdown of
overexpressed and endogenous JIP3 by siRNA was conﬁrmed in
HEK293T cells and cultured neurons, respectively (Supplementary
Figs. 2 and 3), and recovery of JIP3 expression by the siRNA-resis-
tant plasmid for JIP3 was conﬁrmed in HEK293T cells (Supplemen-
tary Fig. 2). These results provide evidence that ARF6/JIP3 signaling
negatively regulates elongation and branching of neurites.
3.4. ARF6/JIP3 signaling regulates elongation of axons and dendrites
and branching of axons
A previous report has suggested that ARF6 regulates axonal and
dendritic formation through distinct downstream cascades [11].
Therefore, we examined which of axonal or dendritic morphogen-
esis is regulated by ARF6/JIP3 signaling. Axons and dendrites were
distinguished by their morphological characteristics (Fig. 4A).
Quantiﬁcation of their morphologies (Fig. 4B and C) was conducted
with cortical neurons immunostained with anti-Tau1 and anti-
MAP2 antibodies for axons and dendrites, respectively (data not
shown). When ARF6T27N and ARF6TriM were overexpressed in
neurons, elongation of axons and dendrites and branching of axons
were stimulated (Fig. 4A–D). ARF6T27N also stimulated dendrite
branching, but ARF6TriM failed to do so (Fig. 4E). These results
indicate that ARF6 negatively regulates not only elongation of ax-
ons and dendrites but also axon branching through its interaction
with JIP3 whereas it regulates dendrite branching through a dis-
tinct downstream signaling pathway(s).4. Discussion
In the present study, we identiﬁed JIP3 as a novel partner pro-
tein of ARF6 and demonstrated that ARF6/JIP3 signaling negatively
regulates elongation of axons and dendrites. JIP3 functions as a
scaffold protein for JNK cascade molecules to efﬁciently activate
JNKs [9,12]. The activation of JNK has been implicated in the elon-
gation and branching of neurites by phosphorylating various cyto-
skeleton-associated proteins [13–15]. These observations raised
the possibility that ARF6 controls neurite morphology by regulat-
ing JNK activity through its interaction with JIP3. However, this
point remains to be clariﬁed.
Recently, Montagnac et al. independently identiﬁed JIP3 and JLP
as partner proteins of ARF6 and demonstrated that JLP functions as
an adaptor between the anterograde motor protein kinesin-1 and
the endosomal cargo [16]. They also showed that the active form
of ARF6 competes with kinesin-1 for binding to JLP (and JIP3),
thereby moving away JLP-associated cargos from the kinesin-1
complex to the dynein–dynactin retrograde motor complex, which
in turn transfers the cargos back to the cell body. Hernández-
Deviez et al. have reported that the inactive form of ARF6 promotes
redistribution of endosomal proteins to the cell surface in rat
hippocampal neurons, which results in enhancement of neurite
growth and branching [17]. These reports, together with our
results, indicate that ARF6 moves away JIP3-associated endosomal
cargos, which contain membrane-constituting materials essential
for neurite elongation, from the neurite tips to the cell body,
2806 A. Suzuki et al. / FEBS Letters 584 (2010) 2801–2806thereby negatively regulating not only elongation of axons and
dendrites but also axon branching.
Although we demonstrated that JIP3 is crucial for the regulation
of neurite morphogenesis as a downstream effector of ARF6, it is
also plausible that another downstream molecule(s) of ARF6 is in-
volved in neurite morphogenesis. A candidate for such a molecule
is PIP5Ka since ARF6 has been reported to inhibit neurite morpho-
genesis by interacting with PIP5Ka [11]. During the preparation of
this manuscript, vezatin was identiﬁed to interact with the inter-
switch region of ARF6 and to regulate dendritic formation [18].
This report suggests that ARF6TriM also interfere with the veza-
tin-mediated pathway, in addition to the JIP3 pathway to regulate
dendriteic formation. It would be of interest to know how these
different partner proteins cooperate to control neuronal morphol-
ogy downstream of ARF6.
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